Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H28O2 |
Molecular Weight | 300.4351 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O
InChI
InChIKey=SHGAZHPCJJPHSC-ZVCIMWCZSA-N
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+
Molecular Formula | C20H28O2 |
Molecular Weight | 300.4351 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:57:55 UTC 2023
by
admin
on
Sat Dec 16 17:57:55 UTC 2023
|
Record UNII |
1UA8E65KDZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
D11AX19
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
WHO-VATC |
QL01XX22
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
WHO-VATC |
QD11AH04
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NDF-RT |
N0000007700
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NCI_THESAURUS |
C804
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NDF-RT |
N0000007700
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
FDA ORPHAN DRUG |
101296
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
WHO-ATC |
D11AH04
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PANRETIN (AUTHORIZED: SARCOMA, KAPOSI)
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NDF-RT |
N0000007700
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NDF-RT |
N0000007700
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
FDA ORPHAN DRUG |
110998
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
WHO-ATC |
L01XX22
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NDF-RT |
N0000175607
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
FDA ORPHAN DRUG |
66592
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
NDF-RT |
N0000007700
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
||
|
FDA ORPHAN DRUG |
708819
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C1574
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
7781
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
7186
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
CHEMBL705
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
m1511
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | Merck Index | ||
|
3862
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
m9558
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
C103303
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
1UA8E65KDZ
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
DTXSID6040404
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
100000089387
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
5300-03-8
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
DB00523
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
81864
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | RxNorm | ||
|
KK-22
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
2645
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
ALITRETINOIN
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
659772
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
SUB00344MIG
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
449171
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
50648
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY | |||
|
1UA8E65KDZ
Created by
admin on Sat Dec 16 17:57:56 UTC 2023 , Edited by admin on Sat Dec 16 17:57:56 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> DERIVATIVE |
|
||
|
TARGET -> AGONIST |
Binding Assay
IC50
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|